« Back
Home /
LYRM3 Antibody

LYRM3 Antibody

Item no.	PRS-5663-0.1mg
Manufacturer	ProSci
Amount	0.1 mg
Category	Antibodies Immunohistochemistry Western Blot ELISA Immunofluorescence Primary Antibodies
Type	Antibody Polyclonal
Format	Liquid
Applications	WB, IF, ELISA, IHC-P
Specific against	Human, Mouse, Rat
Host	Rabbit
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	LYRM3 Antibody: B22, LYRM3, CI-B22, UQOR22, Complex I-B22
Available
Shipping	blue ice or RT
By Research Area	Homeostasis
Homology	Predicted species reactivity based on immunogen sequence: Bovine: (94%)
Immunogen	LYRM3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human LYRM3. The immunogen is located within the last 50 amino acids of LYRM3.
Applications	LYRM3 antibody can be used for detection of LYRM3 by Western blot at 1 - 2 μ g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ g/mL. For immunofluorescence start at 20 μ g/mL. Antibody validated: Western Blot in human samples; Immunohistochemistry in rat samples and Immunofluorescence in rat samples. All other applications and species not yet tested.
Positive Control 1	Cat. No. 1304 - Human Liver Tissue Lysate
Purification	LYRM3 Antibody is affinity chromatography purified via peptide column.
Clonality	Polyclonal
Isotype	IgG
Conjugate	Unconjugated
Buffer	LYRM3 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration	1 mg/mL
Storage Conditions	LYRM3 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Related Products	Cat. No. 5663P – LYRM3 Peptide
Disclaimer	Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Modifications	None
Ncbi Official Symbol	NDUFB9
Accession #	Q9Y6M9
Protein Gi #	8134589
Ncbi Gene Id #	4715
User Note	Optimal dilutions for each application to be determined by the researcher.
Ncbi Official Symbol	NDUFB9
Ncbi Official Full Name	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa
Ncbi Organism	Homo sapiens
Swissprot #	Q9Y6M9
Background	LYRM3 Antibody: LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.
Background References 1	Lin X, Wells DE, Kimberling WJ, et al. Human NDUFB9 gene: genomic organization and a possible candidate gene associated with deafness disorder mapped to chromosome 8q13. Hum. Heredity1999; 49:75-80.
1st Image Caption	Western blot analysis of LYRM3 in human liver tissue lysate with LYRM3 antibody at (A) 1 and (B) 2 μ g/mL.
2nd Image Caption	Immunohistochemistry of LYRM3 in rat liver tissue with LYRM3 antibody at 5 μ g/mL.
3rd Image Caption	Immunofluorescence of LYRM3 in rat liver tissue with LYRM3 antibody at 20 μ g/mL.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.1 mg

available

Delivery expected until 9/6/2024